2026
article
OpenAlex
Janitri Venkatachala Babu, Kandasamy Nagarajan ArulJothi, Ramya Lakshmi Rajendran, Prakash Gangadaran et autres
us, in, kr
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Kruthika Prakash, Janani Balaji, Surya Babu, Ramya Lakshmi Rajendran et autres
Introduction: Nucleolin (NCL) is an established cancer target proposed to modulate the tumor immune microenvironment, but has not been systematically tested across cancers. Objective: To systematically investigate the pan-cancer association of NCL expression with tumor progression, prognosis, and the tumor immune microenvironment, …
in, kr
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
Byeong‐Cheol Ahn, Liya Zhu
Accès ouvert
2026
article
OpenAlex
Prakash Gangadaran, Ramya Lakshmi Rajendran, Muthu Subash Kavitha, Byeong‐Cheol Ahn
Exosomes are 30-150 nm extracellular vesicles that convey molecular information reflecting the physiological and pathological states of their source cells. In precision oncology, they function as a non-invasive "liquid biopsy," enabling real-time monitoring of tumor dynamics and metastasis. However, extreme biofluid heterogeneity …
kr, jp
(code pays fourni par la source)
2026
article
OpenAlex
Janitri Venkatachala Babu, Kandasamy Nagarajan ArulJothi, Ramya Lakshmi Rajendran, Prakash Gangadaran et autres
us, in, kr
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Vidya Sankarapandian, Ramya Lakshmi Rajendran, Conrad Ondieki Miruka, Poornima Sivamani et autres
Breast cancer is a heterogeneous disease with complex molecular pathogenesis. Overexpression of several tyrosine kinase receptors is associated with poor prognosis, therefore, they can be key targets in breast cancer therapy. Tyrosine kinase inhibitors (TKIs) have emerged as leading agents in targeted …
Accès ouvert
2026
article
OpenAlex
Vidya Sankarapandian, Ramya Lakshmi Rajendran, Conrad Ondieki Miruka, Poornima Sivamani et autres
Breast cancer is a heterogeneous disease with complex molecular pathogenesis. Overexpression of several tyrosine kinase receptors is associated with poor prognosis, therefore, they can be key targets in breast cancer therapy. Tyrosine kinase inhibitors (TKIs) have emerged as leading agents in targeted …
Accès ouvert
2026
article
OpenAlex
Prakash Gangadaran, Aswini Suresh Kumar, K Kumaran, Kruthika Prakash et autres
Traditional cancer therapies such as surgery, chemotherapy, and antibody-based treatments often face significant barriers, including systemic toxicity, a lack of selectivity, and the emergence of drug resistance. These issues demand innovative and targeted solutions. Peptide-based therapeutics have gained prominence for their ability …
kr, in
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Ji Min Oh, Liya Zhu, Byeong‐Cheol Ahn
kr
(code pays fourni par la source)
2025
article
OpenAlex
Vijay Murali Ravi Mythili, Vasanth Kanth Loganathbabu Thasma, Shriya Pattabiram, Kumaran Kasinathan et autres
in, kr, Afrique du Sud
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Soumya Deep Phadikar, Ramya Lakshmi Rajendran, Sathish Muthu, Prakash Gangadaran et autres
GrpE-like 1 (GRPEL1)-carrying exosomes derived from synovial mesenchymal stem cells (SMSC) prevent mitochondrial dysfunction associated with osteoarthritis (OA) by activating PINK1-mediated mitophagy, restoring chondrocyte function, and preserving the extracellular matrix both in vitro and in vivo . Bioinformatics analysis of human OA …
in, kr
(code pays fourni par la source)
2025
article
OpenAlex
Madhan Jeyaraman, Naveen Jeyaraman, Arulkumar Nallakumarasamy, Swaminathan Ramasubramanian et autres
in, mx, kr
(code pays fourni par la source)